RelA repression of RelB activity induces selective gene activation downstream of TNF receptors

被引:95
作者
Jacque, E
Tchenio, T
Piton, G
Remeo, PH
Baud, V
机构
[1] Univ Paris 05, CNRS, UMR 8104,Dept Hematol, INSERM,U567,Inst Cochin, F-75014 Paris, France
[2] Ctr Natl Rech Sci, Unite Genet Mol & Integrat Fonct Cellulaires, Unite Propre Rech 1983, F-94801 Villejuif, France
关键词
NF-kappa B; phosphorylation; target gene expression;
D O I
10.1073/pnas.0507342102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
TNF-alpha is a potent proinflammatory cytokine that regulates immune and inflammatory responses and programmed cell death. TNF-a stimulation causes nuclear translocation of several NF-kappa B dimers, including ReIA/p50 and ReIB/p50. However, contrary to ReIA, ReIB entering the nucleus in response to TNF-alpha cannot bind to DNA in mouse embryonic fibroblasts, strongly suggesting that ReIB DNA-binding activity is modulated by additional nuclear mechanisms. Here, we demonstrate that TNF-alpha promotes the association of ReIA with RelB in the nucleus and that TNF-alpha-induced ReIA/ReIB heterodimers do not bind to KB sites. Remarkably, we show that ReIA serine-276, the phosphorylation of which is induced by TNF receptor ligation, is crucial for ReIA/ReIB complex formation and subsequent inhibition of ReIB DNA binding. In the absence of RelA phosphorylation on serine-276, TNF-alpha stimulation leads to a strong increase in the expression of endogenous NF-kappa B-responsive genes, such as Bcl-xL, whose transcriptional up-regulation is mainly controlled by RelB. Our findings demonstrate that ReIA has a major regulatory role serving to dampen ReIB activity in response to TNF-alpha and define a previously unrecognized mechanism that represents an essential step leading to selective NF-kappa B target gene expression.
引用
收藏
页码:14635 / 14640
页数:6
相关论文
共 45 条
[1]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[2]   Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB [J].
Baldwin, AS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) :241-246
[3]   Control of apoptosis by Rel/NF-κB transcription factors [J].
Barkett, M ;
Gilmore, TD .
ONCOGENE, 1999, 18 (49) :6910-6924
[4]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[5]   EMR1, AN UNUSUAL MEMBER IN THE FAMILY OF HORMONE RECEPTORS WITH 7 TRANSMEMBRANE SEGMENTS [J].
BAUD, V ;
CHISSOE, SL ;
VIEGASPEQUIGNOT, E ;
DIRIONG, S ;
NGUYEN, VC ;
ROE, BA ;
LIPINSKI, M .
GENOMICS, 1995, 26 (02) :334-344
[6]   Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers [J].
Bonizzi, G ;
Bebien, M ;
Otero, DC ;
Johnson-Vroom, KE ;
Cao, YX ;
Vu, D ;
Jegga, AG ;
Aronow, BJ ;
Ghosh, G ;
Rickert, RC ;
Karin, M .
EMBO JOURNAL, 2004, 23 (21) :4202-4210
[7]   Transcription of the RelB gene is regulated by NF-κB [J].
Bren, GD ;
Solan, NJ ;
Miyoshi, H ;
Pennington, KN ;
Pobst, LJ ;
Paya, CV .
ONCOGENE, 2001, 20 (53) :7722-7733
[8]   RelB/p50 dimers are differentially regulated by tumor necrosis factor-α and lymphotoxin-β receptor activation -: Critical roles for p100 [J].
Derudder, E ;
Dejardin, E ;
Pritchard, LL ;
Green, DR ;
Körner, M ;
Baud, V .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (26) :23278-23284
[9]  
DOBRZANSKI P, 1995, ONCOGENE, V10, P1003
[10]   NF-KAPPA-B ACTIVATION BY TUMOR-NECROSIS-FACTOR-ALPHA IN THE JURKAT T-CELL LINE IS INDEPENDENT OF PROTEIN KINASE-A, PROTEIN-KINASE-C, AND CA2+-REGULATED KINASES [J].
FEUILLARD, J ;
GOUY, H ;
BISMUTH, G ;
LEE, LM ;
DEBRE, P ;
KORNER, M .
CYTOKINE, 1991, 3 (03) :257-265